Alcon Inc (2U3)
TG
News
Market Data
Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
The current 2U3 market cap is 0. The company's latest EPS is USD 2.0372 and P/E is 45.33.
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 6.83B | 8.29B | 8.72B | 9.46B | 9.91B |
| Operating Income | -482M | 580M | 672M | 1.04B | 1.41B |
| Net Income | -531M | 376M | 335M | 974M | 1.02B |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 27.6B | 28B | 29.21B | 29.61B | 30.35B |
| Total Liabilities | 8.78B | 8.74B | 9.53B | 8.99B | 8.79B |
| Total Equity | 18.82B | 19.26B | 19.68B | 20.62B | 21.55B |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 823M | 1.35B | 1.22B | 1.39B | 2.08B |
| Investing | -572M | -1.2B | -1.87B | -1.09B | -1.17B |
| Financing | 466M | -123M | -8M | -211M | -322M |
| Market Cap | 0 |
| Price to Earnings Ratio | 45.33 |
| Price to Sales Ratio | 4.66 |
| Price to Cash Ratio | 27.53 |
| Price to Book Ratio | 2.14 |
| Dividend Yield | - |
| Shares Outstanding | 499.7M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0 (0%) |
| Company Name | Alcon Inc |
| Address |
rue louis-d'affry 6 fribourg 1701 |
| Website | https://www.alcon.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
